DK160533C - Fremgangsmaade til fremstilling af en fast, bismuthholdig komposition og fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende den saaledes fremstillede komposition - Google Patents

Fremgangsmaade til fremstilling af en fast, bismuthholdig komposition og fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende den saaledes fremstillede komposition

Info

Publication number
DK160533C
DK160533C DK208083A DK208083A DK160533C DK 160533 C DK160533 C DK 160533C DK 208083 A DK208083 A DK 208083A DK 208083 A DK208083 A DK 208083A DK 160533 C DK160533 C DK 160533C
Authority
DK
Denmark
Prior art keywords
preparing
procedure
solid
bism
pharmaceutical preparation
Prior art date
Application number
DK208083A
Other languages
Danish (da)
English (en)
Other versions
DK208083D0 (da
DK160533B (da
DK208083A (da
Inventor
Petrus Johannes Hugo Bos
Dirk Jacob Coenraad Engel
Hayo De Jonge
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of DK208083D0 publication Critical patent/DK208083D0/da
Publication of DK208083A publication Critical patent/DK208083A/da
Publication of DK160533B publication Critical patent/DK160533B/da
Application granted granted Critical
Publication of DK160533C publication Critical patent/DK160533C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/29Antimony or bismuth compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Supply, Installation And Extraction Of Printed Sheets Or Plates (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cereal-Derived Products (AREA)
DK208083A 1981-09-22 1983-05-10 Fremgangsmaade til fremstilling af en fast, bismuthholdig komposition og fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende den saaledes fremstillede komposition DK160533C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30437281A 1981-09-22 1981-09-22
US30437281 1981-09-22
NL8200031 1982-09-21
PCT/NL1982/000031 WO1983001001A1 (en) 1981-09-22 1982-09-21 Bismuth containing composition and method for the preparation thereof

Publications (4)

Publication Number Publication Date
DK208083D0 DK208083D0 (da) 1983-05-10
DK208083A DK208083A (da) 1983-05-10
DK160533B DK160533B (da) 1991-03-25
DK160533C true DK160533C (da) 1991-09-09

Family

ID=23176246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK208083A DK160533C (da) 1981-09-22 1983-05-10 Fremgangsmaade til fremstilling af en fast, bismuthholdig komposition og fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende den saaledes fremstillede komposition

Country Status (17)

Country Link
EP (1) EP0075992B1 (Direct)
JP (1) JPS58501590A (Direct)
AT (1) ATE15598T1 (Direct)
AU (1) AU563692B2 (Direct)
CA (1) CA1198367A (Direct)
DE (1) DE3266403D1 (Direct)
DK (1) DK160533C (Direct)
ES (1) ES8400240A1 (Direct)
FI (1) FI77156C (Direct)
GR (1) GR78040B (Direct)
HU (1) HU193524B (Direct)
IE (1) IE53958B1 (Direct)
NZ (1) NZ201911A (Direct)
PH (1) PH20649A (Direct)
PT (1) PT75550B (Direct)
WO (1) WO1983001001A1 (Direct)
ZA (1) ZA826893B (Direct)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
EP0206626B2 (en) * 1985-06-13 2002-05-22 Barry James Dr. Marshall Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
AU4596796A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
ES2267108T3 (es) * 1995-08-24 2007-03-01 Josman Laboratories, Inc. Composiciones que contienen bismuto en formas de dosificacion topicas.
RU2189942C1 (ru) * 2001-06-26 2002-09-27 Институт химии твердого тела и механохимии СО РАН Способ получения висмут-калий-аммоний цитрата
RU2416571C1 (ru) * 2010-02-15 2011-04-20 Учреждение Российской академии наук Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмута цитрата
RU2496719C1 (ru) * 2012-02-17 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут калий цитрата
RU2570610C1 (ru) * 2014-10-02 2015-12-10 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут аммоний цитрата
RU2675869C1 (ru) * 2018-02-05 2018-12-25 Общество с ограниченной ответственностью "Брайт Вэй" Способ получения висмут-калий-аммоний цитрата

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions

Also Published As

Publication number Publication date
AU8950382A (en) 1983-04-08
PH20649A (en) 1987-03-16
FI77156B (fi) 1988-10-31
AU563692B2 (en) 1987-07-16
WO1983001001A1 (en) 1983-03-31
ATE15598T1 (de) 1985-10-15
IE822299L (en) 1983-03-22
DK208083D0 (da) 1983-05-10
HU193524B (en) 1987-10-28
IE53958B1 (en) 1989-04-26
FI831815L (fi) 1983-05-20
ES515848A0 (es) 1983-10-16
CA1198367A (en) 1985-12-24
FI77156C (fi) 1989-02-10
FI831815A0 (fi) 1983-05-20
JPH0330573B2 (Direct) 1991-04-30
GR78040B (Direct) 1984-09-26
ES8400240A1 (es) 1983-10-16
JPS58501590A (ja) 1983-09-22
DK160533B (da) 1991-03-25
PT75550A (en) 1982-10-01
DE3266403D1 (en) 1985-10-24
ZA826893B (en) 1983-07-27
NZ201911A (en) 1985-10-11
EP0075992B1 (en) 1985-09-18
PT75550B (en) 1984-12-12
EP0075992A1 (en) 1983-04-06
DK208083A (da) 1983-05-10

Similar Documents

Publication Publication Date Title
DK160533C (da) Fremgangsmaade til fremstilling af en fast, bismuthholdig komposition og fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende den saaledes fremstillede komposition
DE3567463D1 (en) 4-dimethylamino-1-hydroxybutane-1,1-diphosphonic acid, its water soluble salts, process for their preparation and its use
NO156010C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, vannopploeselige salter av (+)-katechin.
ES2036519T3 (es) Derivados de peroxidasa estabilizados solubles en agua, procedimiento para su preparacion y utilizacion.
JPS53145922A (en) Remedy for peptic ulcer containing prenyl ketone compound
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
JPS5639782A (en) Stabilization of thrombin
NO159381C (no) Glutaraldehydforloeper og fremstilling derav.
FI812853A7 (fi) Dihydro-1H-pyrrolitsiini-3,5(2H,6H)- dionin käyttö tajuntakykyä aktivoivana aineena ja menetelmä sen valmisvalmistamiseksi.
DK142578C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-benzylpyrimidiner og syreadditionssalte deraf
JPS5249248A (en) Reverse osmotic treatment of water-soluble electro-deposition coating
IT7950044A0 (it) Procedimento per la preparazione di 1,2-polibutadiene
JPS52108013A (en) Artificial saliva
JPS55167220A (en) Antitumor drug
IT1112649B (it) Composto chimico eterociclio 6-fenil-(1,2,3)-oxadiazolo-(4,5 d)-piridazin-7(6h)-one e procedimento per la sua produzione
JPS5424863A (en) 2-pheyl anthraquinonedisulfonic acid, and its salts, their preparation, oxidation-reduction agents for wet desulfurization using them
JPS53149939A (en) Novel benzyl alcohol derivatives and their preparation
JPS51115432A (en) Process for preparation of protocatechualdehyde
NO793111L (no) Biologisk aktive polypeptider og syreaddisjonssalter derav, og fremgangsmaate for fremstilling derav
JPS5217465A (en) Preparation of 4-iodo-5-bromoindole-3- phosphates
JPS5218830A (en) Homoisotwistylamines antiviral agents for animals
JPS5287140A (en) Preparation of optically active p-hydroxyphenylglycine
JPS5396330A (en) Antiulceratives
JPS53142873A (en) Etching method of gaas group compound semiconductor crystal
PT74363A (en) Process for preparing sparingly water-soluble salts of penicil-lanic acid 1,1-dioxide

Legal Events

Date Code Title Description
PBP Patent lapsed